Cited by 367Cutaneous lymphoproliferative disorders researchT-cell and B-cell ImmunologyT-cell and Retrovirus Studies

Skin Effector Memory T Cells Do Not Recirculate and Provide Immune Protection in Alemtuzumab-Treated CTCL Patients

Open access
Clark, Rachael A., Watanabe, Rei, Teague, Jessica E., Schlapbach, Christoph, Tawa, Marianne C., Adams, Natalie, Dorosario, Andrew A., Chaney, Keri S. +5 more·2012·Science Translational Medicine

Abstract

Alemtuzumab depletes malignant T cells but spares skin resident effector memory T cells, treating L-CTCL without increased risk of infection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.3003008

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Both CD8+ and CD4+ Trm have been identified in human skin, lung, intestines, salivary glands, bone marrow, brain, spleen, tonsils, and lymph nodes.

    “Both CD8+ and CD4+ Trm have been identified in the human skin, lung, intestines, salivary glands, bone marrow, brain, spleen, tonsils, and lymph nodes [241, 244, 246, 253-259].”

    From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [246]

    The Results section ('Alemtuzumab therapy leaves intact a diverse population of skin resident TEM'; page unavailable) identifies both CD4+ and CD8+ memory T cells remaining in human skin. The Discussion says residence in lung and gastrointestinal tissue is only suggested and 'remains to be demonstrated'; it does not establish the claim for the other listed organs. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Trm have been defined as independent populations by tissue retention in parabiosis experiments, by distinguishing transcriptional profiles, by exclusive Ag receptor repertoires and specificities, and by exclusive persistence in transplanted tissues.

    “They have been defined as independent populations by tissue retention in parabiosis experiments [239, 240], by distinguishing transcriptional profiles [230, 241-245], by exclusive Ag receptor repertoires and specificities [243, 244, 246], and by exclusive persistence in transplanted tissues [247, 248].”

    From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [246]

    The Results and Discussion report that skin effector memory T cells remained after alemtuzumab treatment and appeared non-recirculating. The citation is attached to persistence in transplanted tissues, but our copy provides no transplantation evidence; searches for transplanted tissue, grafts, and donor–recipient persistence found none. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 53 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Clark, R. A., Watanabe, R., Teague, J. E., Schlapbach, C., Tawa, M. C., Adams, N., Dorosario, A. A., Chaney, K. S., Cutler, C. S., LeBoeuf, N. R., Carter, J. B., Fisher, D. C., & Kupper, T. S.
Affiliations
  • Brigham and Women's Hospital (US)
  • Dana-Farber Brigham Cancer Center (US)
  • Massachusetts General Hospital (US)
Corresponding author
  • Clark, Rachael A.
  • Watanabe, Rei
  • Kupper, Thomas S.
Venue
Science Translational Medicine
Published
2012-01-18
Volume
4
Issue
117
Pages
117ra7-117ra7
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2076870975
Cited by
367
References
53
Citations by year
2026: 6 · 2025: 17 · 2024: 17 · 2023: 18 · 2022: 25 · 2021: 38 · 2020: 27 · 2019: 27 · 2018: 33 · 2017: 26 · 2016: 31 · 2015: 37 · 2014: 25 · 2013: 20 · 2012: 19
FWCI
40.39
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • U.S. Public Health Service (R01 A1025082)
  • National Cancer Institute (P50 CA9368305, P50CA093683)
  • National Institute of Allergy and Infectious Diseases (R37AI025082, R01AI097128)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR056720, R01AR065807)
Topics
  • Health Sciences › Medicine › Dermatology › Cutaneous lymphoproliferative disorders research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Keywords
cutaneous T-cell lymphoma, alemtuzumab, central memory T cells, effector memory T cells, mycosis fungoides, T cell recirculation, skin-homing T cells, neutrophils, IL-4, interferon-gamma, infection susceptibility, T cell depletion
MeSH terms
CD52 Antigen, Alemtuzumab, Aged, Aged, 80 and over, Antigens, Neoplasm, Antineoplastic Agents, Female, Glycoproteins, Humans, Immune System, Immunologic Memory, Male, Middle Aged, Mycosis Fungoides, Neutrophils, Phenotype, Skin, T-Lymphocytes, T-Lymphocytes, Cytotoxic, Antigens, CD, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review